GenScript and Tamarind Bio Connect AI Molecular Design With Lab Validation

Aug 6, 2026
GenScript Biotech Corporation and Tamarind Bio have partnered to let researchers submit AI generated molecular designs for synthesis, expression, and testing through GenScript's laboratory services.

GenScript Biotech Corporation and Tamarind Bio have partnered to connect Tamarind Bio's AI powered molecular design platform with GenScript's laboratory validation services, the companies announced in a press release.

The workflow lets researchers using Tamarind Bio submit AI generated sequences to GenScript for synthesis, expression, and testing. GenScript said its laboratory infrastructure can produce experimental data from digital sequences in as little as four days.

Tamarind Bio's platform gives biologics and small molecule researchers access to more than 300 computational biology models. The companies said the integration is intended to reduce manual handoffs between molecular design and laboratory validation.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Guide
Specialist Ambient Medical Scribe Vendors

Specialist Ambient Medical Scribe Vendors

AI scribes that turn medical consultations into draft clinical notes

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.